New weekly update with 2 purchases.
#dividend
#dividends
#dividende
#stocks
#stock
#invest
#investing
#etf
#etfs
$JNJ (-0,45%)
$PFE (+0,36%)
$ABBV (+1,28%)
$LLY (+0,07%)
$MRK (-0,45%)
Postos
336Bought 4 shares of Johnson&Johnson $JNJ (-0,45%) today at an average price of $153,52 including transaction costs.
I currently own 22 shares. This gives me an annual dividend of approximately €101 per year.
This was bought with the money on Etoro received from sold shares and received dividends, I still have to spend the weekly €250
#dividend
#dividends
#dividende
#invest
#stocks
#stock
#invest
#investing
Is $JNJ (-0,45%) a tubular failure
what do you think
Hello my dears...
There have been adjustments to the Sina 40
Out:
$JNJ (-0,45%)
$ALV (+0,01%)
$CS (-0,76%)
$NVDA (-0,14%)
$7974 (+1,75%)
$ULVR (-0,42%)
$NFLX (+0,02%)
NVIDIA only 50%
apart from j+J, there was considerable profit-taking in some cases (I think 25% is comparatively high for a company like Unilever)
In:
$ANET (+2,63%)
$ORCL (+4,75%)
$6857 (-1,96%)
$AVGO (+1,16%)
$TXN (+0,56%)
$COST (-0,44%)
Stocked up:
The remaining cash is € 2330, which will remain there for the time being. Currently the Sinas is 40, therefore only one Sinas 39. Let's see where the cash will then go in number 40
PS: the chart has been completely messed up by the adjustments. We were actually at 2.71 % 1 Y
The ongoing lawsuits over allegedly carcinogenic talcum powder products have put Johnson under pressure.
A US federal judge has refused to resolve the matter via insolvency proceedings.
The financial risk at Johnson is high, new uncertainty in the strategic direction.
Johnson the new Bayer $BAYN (-5,03%) and 3M $MMM (-0,18%) ?
Bottomless pit, the share has been in a volatile downward trend since 2022. Once again, the upper boundary line was not broken.
Principais criadores desta semana